Inventor · Chatswood, AU

Matthew Pollard

22Patents
4h-index
35Co-inventors
59Inventor score

Filing activity: Oct 16, 2006 → Jun 21, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7560688B2 Mass analysis of mobility selected ion populations Electricity 18 Active
US10138296B2 Antibodies that specifically bind to TL1A Chemistry; Metallurgy 7 Active
US9963515B2 Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B Chemistry; Metallurgy 5 Active
US9611322B2 Fusions of antibodies to CD38 and attenuated interferon alpha Chemistry; Metallurgy 5 Active
US10544199B2 Interferon alpha 2B variants Chemistry; Metallurgy 3 Active
US11220549B2 Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseases Chemistry; Metallurgy 2 Active
US10822422B2 Antibodies against TL1a and uses thereof Chemistry; Metallurgy 2 Active
US10981986B2 Fusions of antibodies to CD38 and attenuated interferon alpha Chemistry; Metallurgy 1 Active
US10906973B2 Antibody variants transmigrating the blood-brain barrier and uses thereof Chemistry; Metallurgy 1 Active
US11725052B2 Anti-PAR-2 antibodies and methods of use thereof Chemistry; Metallurgy 1 Active
US8470320B2 Humanised antibodies with anti-tumour activity Chemistry; Metallurgy 1 Active
US9127057B2 Anti-IL-23 heterodimer specific antibodies Chemistry; Metallurgy 1 Active
US11267883B2 Antibodies that specifically bind to human IL-15 and uses thereof Physics 1 Active
US11117975B2 Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B Chemistry; Metallurgy 1 Active
US11319356B2 Interferon alpha 2B variants Chemistry; Metallurgy 0 Active
US12384841B2 Anti-PAR-2 antibodies and methods of use thereof Chemistry; Metallurgy 0 Active
US11332534B2 Anti-CXCR2 antibodies and uses thereof Physics 0 Active
US12018084B2 Anti-CXCR2 antibodies and uses thereof Physics 0 Active
US12162946B2 Antibodies that specifically bind to TL1A and methods of treating gastrointestinal disease Chemistry; Metallurgy 0 Active
US12410247B2 Polynucleotides encoding antibodies that specifically bind to human IL-15 Physics 0 Active
US8901279B2 Humanized antibodies with anti-tumor activity Chemistry; Metallurgy 0 Active
US12410256B2 Antibodies that specifically bind to TL1a and methods of treating gastrointestinal or lung diseases Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.